Boston Scientific Completes Clinical Trial Enrollment for Third-Generation Drug-Elu... ( PERSEUS clinical program to evaluate ...)

Boston Scientific Completes Clinical Trial Enrollment for Third-Generation Drug-Eluting Stent

Date:10/8/2008

PERSEUS clinical program to evaluate TAXUS(R) Element(TM) Platinum Chromium

Stent

NATICK, Mass., Oct. 8 /PRNewswire-FirstCall/ -- Boston Scientific Corporation (NYSE: BSX) today announced that it has completed enrollment in the PERSEUS trial, designed to evaluate the Company's third-generation TAXUS(R) Element(TM) paclitaxel-eluting coronary stent. The PERSEUS clinical program has enrolled nearly 1,500 patients at 100 U.S. and international centers since July 2007, and will compare the TAXUS Element Stent to the prior-generation TAXUS(R) Express2(TM) Stent marketed in the United States since 2004. The Company plans to develop additional versions of the Element platform, including next generations of a bare-metal stent and an everolimus-eluting PROMUS(R) Element stent system.

"We are pleased to reach this important milestone in the development of our third-generation drug-eluting stent, at a time when most companies are still introducing their first-generation stents in the U.S.," said Keith Dawkins, M.D., Senior Vice President and Associate Chief Medical Officer for Boston Scientific. "Boston Scientific is the only company to offer interventionalists a choice between two different drugs in a DES platform. The advanced Platinum Chromium Alloy and new balloon catheter offered in the Element system will further strengthen our deep portfolio of coronary stent technologies."

The Element Stent platform features the proprietary Platinum Chromium Alloy, designed specifically for stents. This alloy, coupled with an innovative new stent architecture, is designed to enable thinner struts for increased flexibility, a lower profile, and improved radial strength, recoil, and radiopacity. In addition,
'/>"/>

SOURCE Boston Scientific Corporation
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4
Related medicine technology :

1. Wound Management Technologies, Inc. Announces Conference Plans in Boston and Additional Clinical Research on CellerateRx(R)
2. NIH Funds New Wellstone Research Center for Muscular Dystrophy at Boston Biomedical Research Institute
3. Boston Scientific Announces Schedule for European Society of Cardiology Congress 2008
4. Boston University and The Center for Human Genetics, Inc. Announce Change in Testing Services
5. Headache Specialists Convene in Boston For 50th Annual American Headache Society Meeting
6. Leading Immunologists Convene in Boston
7. Seven Presentations by Two Independent Research Groups Highlight Advantages of Pressure Cycling Technology (PCT) at Scientific Symposia in Philadelphia, Boston, and New York City
8. Multi-Center Patient Registry Supports Safety and Clinical Utility of Boston Scientifics SpyGlass(R) Direct Visualization System
9. SPIRIT III Results Reaffirm Strong Performance of Boston Scientific PROMUS(TM) and TAXUS(R) Express(R) Stents
10. Cequent Pharmaceuticals Johannes Fruehauf, MD, Ph.D., to be Featured Speaker at RNAi World Congress in Boston - May 2, 2008
11. Spirit II Results Support Strength of Boston Scientifics Two Drug-Eluting Stent Platforms

Post Your Comments:

(Date:11/25/2009)...re-FirstCall/--HeskaCorporation(HSKA);("Heska"),al...oductstotheveterinaryindustry,announcedtodayagreem...loodgasproductsandaffiliatedconsumablesfortheveter...gi-bin/prnh/20000622/HESKALOGO ) ,, "HeskaandRo...ancedpoint-of-carediagnostics,"commentedMichaelMcG...

(Date:11/25/2009)...re-FirstCall/--Pharmasset,Inc.(Nasdaq: VRUS ),acli...ing,developingandcommercializingnoveldrugstotreatv...lyearendedSeptember30,2009.AtSeptember30,2009Pharm...tterminvestments. ,, PipelineUpdateand2009High..., InlateNovember2009,anindependentDataMonitoringCo...

(Date:11/25/2009)...v.25/PRNewswire/-- FromNovember16-18,Phonak,thelea...ntedthesecondeditionoftheHearingCareforAdultsConfe...n.Theconferencebroughttogetherleadingexpertsinagin...cianswhoworkeverydaywitholderpeoplewithhearingloss...estresearchandtrendsinhearingcareforolderpeople. ...

Breaking Medicine Technology:Heska Announces Supply Agreement With Roche Diagnostics 2 Heska Announces Supply Agreement With Roche Diagnostics 3 Pharmasset Reports Fiscal Year End 2009 Financial Results 2 Pharmasset Reports Fiscal Year End 2009 Financial Results 3 Pharmasset Reports Fiscal Year End 2009 Financial Results 4 Pharmasset Reports Fiscal Year End 2009 Financial Results 5 Pharmasset Reports Fiscal Year End 2009 Financial Results 6 Pharmasset Reports Fiscal Year End 2009 Financial Results 7 Pharmasset Reports Fiscal Year End 2009 Financial Results 8 Phonak Successfully Hosts Hearing Care for Adults 2009 Conference 2 Phonak Successfully Hosts Hearing Care for Adults 2009 Conference 3 Men with Low Testosterone See Multiple Doctors Before Being Diagnosed 3B Many Dissatisfied with Current Treatment Options 48431 1 Men with Low Testosterone See Multiple Doctors Before Being Diagnosed 3B Many Dissatisfied with Current Treatment Options 48431 2 Men with Low Testosterone See Multiple Doctors Before Being Diagnosed 3B Many Dissatisfied with Current Treatment Options 48431 3 Men with Low Testosterone See Multiple Doctors Before Being Diagnosed 3B Many Dissatisfied with Current Treatment Options 48431 4 Men with Low Testosterone See Multiple Doctors Before Being Diagnosed 3B Many Dissatisfied with Current Treatment Options 48431 5 Men with Low Testosterone See Multiple Doctors Before Being Diagnosed 3B Many Dissatisfied with Current Treatment Options 48431 6 TOPAZ Technologies Introduces Biosafety Software Solution 48428 1 TOPAZ Technologies Introduces Biosafety Software Solution 48428 2 TOPAZ Technologies Introduces Biosafety Software Solution 48428 3 BioMarin to Present at the Jefferies Healthcare Conference 12559 1 BioMarin to Present at the Jefferies Healthcare Conference 12559 2

[0] Heska Announces Supply Agreement With Roche Diagnostics [0] Pharmasset Reports Fiscal Year End 2009 Financial Results [0] Phonak Successfully Hosts Hearing Care for Adults 2009 Conference

...Technologies, Inc. (TriLink), a leading provider o...d a new Hot Start PCR reagent - CleanAmp(TM) dNTPs...olution to improved hot start PCR results. Using ...tart of PCR thermal cycling by blocking DNA polyme.... The temperature dependent control of DNA polyme...

...InspireMD, developers of,MGuard(TM), announced tod...,iMOS registry. MGuard(TM) was successfully implan...the procedure was performed by Dr. Jan Horak. , ...rd(TM) patients. The,registry, which is a post mar...outh America. Data from the registry, an unselecte...

Other Medicine Technology:InspireMD Announces the Enrollment of the 1st Patient in the MGuard iMOS Registry, the Registry Will Enroll 1000 Patients 2 InspireMD Announces the Enrollment of the 1st Patient in the MGuard iMOS Registry, the Registry Will Enroll 1000 Patients 3

TriLink Launches CleanAmp(TM) dNTPs for Hot Start PCR InspireMD Announces the Enrollment of the 1st Patient in the MGuard iMOS Registry, the Registry Will Enroll 1000 Patients

(Date:11/27/2009)...rance,Nov.27/PRNewswire/--TeamGarmin-Slipstream,th...hicalsportinganddevelopingthenextgenerationofcycli...in-TransitionswiththeadditionofTransitionsOpticala...,sleadingmanufacturerofadaptiveeyewear,offeringthe...tionofspectaclelensessuchasTransitionslensesaswell...

(Date:11/27/2009)...wswire/-- Allrecipes.com , theworld,s#1foodsite,r...orethan2.8millionvisitorsthedaybeforeThanksgiving,...oodholidayoftheyear.TheaverageThanksgivingmealin20...easefromlastyear,sfeast.AccordingtotheAllrecipessi...anksgivingrecipe,acontrastfromlastyear,spopular Ho...

(Date:11/26/2009)...wswire/--Withcoldandfluseasonuponus,it,smoreimport...ofinfectionsandavoidillness. ,, "Weneedtobeproa...mittingillnessifwe,resick,"saidEileenFinerty,RN,MS...forinfectioncontrolandoccupationalhealthatHospital...orSpecialSurgeryhasoneofthelowestinfectionratesofa...

(Date:11/26/2009)...en on an emotional rollercoaster, study finds , ...ll it the fear factor meets the jubilant sports fa...pecially those who root for the winning team -- en...ntested match and victory was in doubt, producing ...hat this Thanksgiving weekend as you,re glued to t...

(Date:11/26/2009)...nnis & Ennis, P.A. is offering free nationwide...asmin birth control pills who have suffered a Deep..., Heart Attack or other related cardiac issues or ... free at 1-800-856-6405 or go to the firm’s ...an online case evaluation form. , ...

Breaking Medicine News(10 mins):Health News:Team Garmin-Slipstream Officially Re-named Team Garmin-Transitions With Addition of Transitions Optical as New Sponsor 2 Health News:Team Garmin-Slipstream Officially Re-named Team Garmin-Transitions With Addition of Transitions Optical as New Sponsor 3 Health News:It's Black Friday - Time to Shop Off the Calories! Allrecipes Finds Average Thanksgiving Meal Weighed in at 2,225 Calories 2 Health News:It's Black Friday - Time to Shop Off the Calories! Allrecipes Finds Average Thanksgiving Meal Weighed in at 2,225 Calories 3 Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 2 Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 3 Health News:Watching the Nail-Biting Big Game Hurts So Good 2 Health News:Watching the Nail-Biting Big Game Hurts So Good 3 Health News:Ennis & Ennis, P.A. Announces Nationwide Free, Confidential, Consultations For Users Of Yaz And Yasmin Birth Control Pills 2 Health News:Ennis & Ennis, P.A. Announces Nationwide Free, Confidential, Consultations For Users Of Yaz And Yasmin Birth Control Pills 3

[0] Team Garmin-Slipstream Officially Re-named Team Garmin-Transitions With Addition of Transitions Optical as New Sponsor [0] It's Black Friday - Time to Shop Off the Calories! Allrecipes Finds Average Thanksgiving Meal Weighed in at 2,225 Calories [1] Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use [0] Watching the Nail-Biting Big Game Hurts So Good [0] Ennis & Ennis, P.A. Announces Nationwide Free, Confidential, Consultations For Users Of Yaz And Yasmin Birth Control Pills

...s say soaring health costs and medical crises fuel...AY, Oct. 28 (HealthDay News) --Since 1999, Keith a...heir health insurance deductible soar from $1,000 ...eborah,s connective tissue disorder and fallen arc...

...ipo MPX Workstation and International Business Dri...secutive Quarter of Profitability, WESTFORD, Mass...ding developer and manufacturer of a broad array o...008 Financial Results, Revenues increased to $38....

...TON, N.J., Oct. 28 Pharmasset, Inc.,(Nasdaq: VRU...or event from,the American Association for the Stu... 2008 starting at 5:30 PM PT. During this webcast,...t of this event via the internet, log on,to the "E...

...NATI, Oct. 28 LCA-Vision Inc. (Nasdaq:,LCAV), a l...s under the,LasikPlus(R) brand, today announced fi...hs and nine months ended September 30, 2008., Thi...4.6 million; adjusted,revenue was $33.0 million co...

...DGE, Mass. and COLUMBUS, Ohio, Oct. 28 ,Intelligen...ucleic acid,assays, today announced that it is wor...ogy (BEST) Center to conduct assay performance,ver...ious testing of,IntelligentMDx,s Quantitative BK V...

...DGE and WOBURN, Mass., Oct. 28 Galenea Corp.,toda...ix, Inc. and its,academic collaborators that gives...tment of obesity and other related disorders. The ...nds have demonstrated potent 5-HT2C receptor agoni...

Medical Debt Sending Many Over Financial Brink Cynosure Reports 21% Revenue Growth for the Third Quarter of 2008 Pharmasset to Webcast an Investor Event from the AASLD Meeting LCA-Vision Reports Third Quarter 2008 Financial Results Battelle to Perform Verification Studies of IntelligentMDx's Proprietary Molecular Diagnostic Assay Process Galenea and Organix Announce Exclusive License Agreement for 5-HT2C Agonists for the Treatment of Obesity

Tungsten Micro Needles

Monopolar Forceps

...tate of the art in inverted microscopy from Zeiss....ge of ICS objectives, with innovative condensers a...al scope of sophisticated documentation and adapta...onomically designed. And Axiovert 200 M, fully mot...

...00 is an innovative and efficient inverted routine...y research facility. Improved mechanics and increa...he TS100 binocular and TS100-F trinocular models. ...rt that accepts Nikon's FX-III series photomicrogr...

Medicine Products:

Tungsten Micro Needles Monopolar Forceps Axiovert 200 Eclipse TS100/TS100F

Boston Scientific Completes Clinical Trial Enrollment for Third-Generation Drug-Elu...( PERSEUS clinical program to evaluate ...),Health